Is Dechra Pharmaceuticals stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Dechra Pharmaceuticals pays dividends. Last time was Thursday 13th of April 2023 where the investors holding the stock on Thursday 9th of March 2023 were paid $0.125 per share. Over the last 13 times between 2016 and 2023, Dechra Pharmaceuticals has paid $2.1752 with an average of $0.17 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Dechra Pharmaceuticals 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $33.90, you would have made a profit of $13.00 per share or 38.35%
No, the average daily trading liquidity for Dechra Pharmaceuticals is $92 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Dechra Pharmaceuticals has N/A of the business financed by loans. This puts the company at N/A risk in periods of high inflation where borrowing costs usually go up. With a N/A cash flow to debt ratio of 0, the company's ability to pay off the debt is N/A. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Dechra Pharmaceuticals to be low [0 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.